Biocomposites Limited is a world-leading medical devices company specializing in the design, manufacture, and commercialization of innovative solutions for infection management within bone and soft tissue. Established in 1996, the company operates from its C/O Biocomposites Limited Keele Science Park facility in Newcastle, ST5 5NL, UK. Biocomposites focuses primarily on developing and supplying advanced composite materials and devices designed to improve patient outcomes in critical areas of bone and soft tissue healing. Their product portfolio includes specialized implants, surgical guides, and wound management systems. The company’s core expertise lies in utilizing biocomposites – a novel material combining biological components with advanced polymer technology – to achieve enhanced biocompatibility, durability, and functionality. Biocomposites boasts a significant international presence, with operations spanning across Europe, North America, and Asia. The company employs a global team of skilled professionals, including engineers, scientists, and regulatory specialists, driving innovation and ensuring adherence to stringent quality standards. They are currently a Visa-skilled worker, holding a Worker (A) rating, reflecting their significant contributions to the medical device industry. Their SIC codes include: - 32500 (Manufacture of medical and dental instruments and supplies) and - 3811 (Medical device manufacturing).

Biocomposites Limited is a world-leading medical devices company specializing in the design, manufacture, and commercialization of innovative solutions for infection management within bone and soft tissue. Established in 1996, the company operates from its C/O Biocomposites Limited Keele Science Park facility in Newcastle, ST5 5NL, UK. Biocomposites focuses primarily on developing and supplying advanced composite materials and devices designed to improve patient outcomes in critical areas of bone and soft tissue healing. Their product portfolio includes specialized implants, surgical guides, and wound management systems. The company’s core expertise lies in utilizing biocomposites – a novel material combining biological components with advanced polymer technology – to achieve enhanced biocompatibility, durability, and functionality. Biocomposites boasts a significant international presence, with operations spanning across Europe, North America, and Asia. The company employs a global team of skilled professionals, including engineers, scientists, and regulatory specialists, driving innovation and ensuring adherence to stringent quality standards. They are currently a Visa-skilled worker, holding a Worker (A) rating, reflecting their significant contributions to the medical device industry. Their SIC codes include: - 32500 (Manufacture of medical and dental instruments and supplies) and - 3811 (Medical device manufacturing).